Execution is the differentiator. A 30-day diagnostic pinpoints where revenue is leaking — and how to recover it. Book a Revenue Diagnostic
What's Broken Execution Gap Diagnostic Proof Who This Is For FAQ Book a Call
Fractional CRO for Wine & Spirits Companies

Demand is under pressure.
Execution is now the difference.

Strong teams operate across complex portfolios, distributor networks, and pricing structures — yet performance often leaks underneath.

Tariffs are compressing margins. Distributor consolidation is reshaping 11 states. Demand is shifting structurally. Execution is now the difference.

Designed for established wine & spirits companies operating at scale — not early-stage brands.

25 years in wine & spirits $22M P&L managed 28 states built Conducted in EN • FR • ES
Track Record
$22M
P&L Managed
40%
Revenue Growth
28
States Built
#1
National Ranking
Now accepting engagements — limited capacity
$22M
P&L Managed
40%
Revenue Growth
28
States Covered
#1
National Ranking
3
Languages
−8.1%
Wine Vol Q1 2026

Recognizable across the industry.
Rarely named at the right level.

Distributor focus is spread across too many priorities. As portfolios grow, attention per brand erodes. Most brands receive less attention than their position warrants.

Portfolio breadth creates execution complexity. More SKUs means less focus per brand, weaker pricing discipline, and thinner distributor engagement.

Pricing varies across markets without clear structure. What is set centrally rarely holds at every tier — and the full picture is seldom visible in one place.

Sales activity is high, but visibility into performance is limited. Calls, samples, and placements are logged. What is actually converting — and where velocity is lost — often isn’t.

Commercial decisions are often reactive, not structured. Promotions respond to shortfalls. Distributor changes follow poor results. By the time the signal arrives, the revenue has already moved.

What is happening at the account level is largely invisible. Leadership sees depletion totals — rarely what is driving them, or working against them.

Strong teams can still underperform inside fragmented commercial systems. The issue is rarely effort or capability. It is structure, visibility, and alignment.

Revenue doesn’t disappear overnight.
It erodes through structural misalignment.

The distributor relationship that worked three years ago is now passive. The pricing built for a growth market no longer holds. The KPI system tracks effort, not outcomes. These gaps compound quietly — and become expensive before they surface.

This is rarely a talent issue. It is a structural one.

Experienced teams underperform when the commercial system hasn’t kept pace with portfolio size, channel complexity, or distributor fragmentation. Structural misalignment creates blind spots that effort alone cannot close.

Complexity grows faster than the systems built to manage it

Each new market, SKU, or distributor relationship adds complexity. Without the infrastructure to manage it — account priorities, depletion visibility, pricing discipline — gaps accumulate silently.

Pricing was built for a different market

Tariffs, margin compression, and channel shifts have changed the economics at every tier. Without a full margin stack review, it is hard to know whether the product is profitable for the people selling it — or whether pricing will hold.

Measurement systems track effort, not revenue performance

Activity metrics track inputs. They do not measure whether those inputs generate revenue. When the system optimizes for effort, it hides exactly where performance is breaking down.

10–30% of revenue.
Execution. Not demand.

Most wine and spirits companies are losing 10–30% of revenue to execution gaps — not to weak demand. The commercial system has structural problems that widen faster than they get fixed. The causes are consistent. So are the solutions.

Portfolio overload

As SKU count grows, commercial attention per brand shrinks. Distributors carry the full portfolio and actively sell a fraction of it. High-potential brands receive less support than their position in the market warrants.

Distributor misalignment

Distributor relationships fragment as portfolios and markets expand. Without active management of rep engagement and account prioritization, the gaps widen. The contract looks intact. The depletion data tells a different story.

Pricing disconnect

Pricing is set at one point in time. Distributor margins, retailer expectations, and on-premise economics shift continuously. Most price architectures are not reviewed end to end. The result is compression that is hard to see until it becomes a margin problem.

No execution visibility

Depletion data shows what sold. It does not show where the commercial organization is performing well, where it is drifting, or where velocity is lost between the pitch and the shelf. Without execution visibility, decisions rely on incomplete information.

Execution — not brand — is now the main driver of performance. The companies gaining ground have tighter commercial systems, clearer distributor accountability, and pricing that holds at every tier.

The market is harder to navigate.
External pressure reveals what was already fragile.

The shifts are real — for importers managing margins, distributors under pressure to prioritize, producers navigating the three-tier system, and international wineries building or fixing their U.S. position. Market conditions do not explain underperformance. They expose it.

US wine volume down 8.1% in Q1 2026. Accelerating, not stabilizing. Q1 2026 is worse than H2 2025’s 9.7% decline. One U.S. winery closed every day in 2025. This is a structural demand reset — and Q1 2026 data shows the baseline is still moving.
Spirits RTDs up 25.7%. Now 26% of spirits volume. NoLo crossed $1B. Consumers are reallocating, not quitting. Spirits RTDs are the one consistent growth category. Traditional wine and spirits formats are competing for the same occasions against products purpose-built for how people drink now.
GLP-1 drugs: 4–7% of US adults using now. 24% considering. Consumption down 29–75%. Clinical data shows GLP-1 users drink 29% less frequently, with some reporting physical discomfort when consuming alcohol. Generics arrive 2026–27. This demand destruction is pharmacological — it does not reverse when tariffs normalize or the economy improves.
11 states. One distributor transaction. Closing May 2026. Reyes is absorbing RNDC operations across Arizona, Colorado, Florida, Louisiana, Oklahoma, Texas and five more states. Hundreds of suppliers have weeks — not months — to re-establish relationships before losing distributor priority.
10% EU import tariff in effect. Escalation to 15% expected by Q3 2026. Importers are caught between absorbing cost — destroying margin — or raising prices into a declining market. European producers face single-digit net margins. Retail pricing built before April 2025 almost certainly doesn’t hold today.

External pressure is not creating the problem — it is revealing it. The companies holding position had already built tight commercial systems before the market got harder. Complexity exposed the ones that had not.

Category Volume Performance — Q1 2026 vs Prior Year
Spirits RTDs
+25.7%
Spirits (All)
−4.7%
Wine (Still + Sparkling)
−8.1%
Source: WSWA SipSource Q1 2026  /  Beall Wine & Spirits Partners Market Intelligence Report April 2026

Sources: WSWA SipSource Q1 2026  /  Beall Wine & Spirits Partners Market Intelligence Report April 2026  /  IWSR  /  NielsenIQ  /  Morgan Stanley  /  Shanken News Daily March 2026

The Commercial Diagnostic —
Where revenue leakage gets identified and fixed.

For importers managing tariff-compressed margins, self-distributing importer-distributors absorbing fixed costs in a declining market, producers navigating the three-tier system, and international wineries building or fixing their U.S. position — this is the structured entry point. Not a proposal. A diagnostic process that locates exactly where the commercial system is underperforming and delivers a specific plan to fix it. Scope can be focused — a specific market, channel, or part of the business — or full-organization from the start.

Step 1 — Alignment & Access  /  Week 1

Establish leadership sponsorship, data access, and clear scope.

Three conditions must be in place before work begins: leadership sponsorship, direct access to data and teams, and a clear brief on who owns the outcome. The CEO or founder must be actively involved — not simply kept informed.

  • Depletion data — by account, market, and SKU
  • Distributor agreements and current pricing architecture
  • Direct access to the commercial team — reps, managers, leadership
  • Clear scope: what is included, what is not, and who owns the outcome
Why most commercial work fails to land: The diagnosis is accurate. The recommendations are sound. But no one inside has the authority, access, or accountability to act. This step closes that gap before the work starts.
Step 2 — 30-Day Diagnostic Sprint  /  Weeks 1–4

A focused diagnostic. Specific findings. A written action plan.

A focused diagnostic across three areas. Every finding is specific to this business — not benchmarked against an industry average. Every recommendation is prioritized and sequenced. The output is a written action plan, not a slide deck of observations.

  • Distributor execution — relationship health, account penetration, depletion velocity, rep engagement, programming ROI
  • Pricing and margin architecture — full stack from landed cost through all channels to shelf and on-premise
  • Commercial team structure — time allocation, KPI design, and where accountability is clear or absent
  • Written 90-day action plan — prioritized, sequenced, specific to this business
What You Receive

A written action plan. 30 days.

Specific to your operation. Prioritized by revenue impact. No generic benchmarks.

Distributor relationship scoring across all markets
Full margin stack analysis & pricing recovery map
Commercial team structure & KPI audit
Written 90-day action plan
Executive presentation to leadership
AI-assisted depletion and execution analysis
Book a Revenue Diagnostic
or
Send a Direct Email
Engagement Path
Phase 0  ·  Week 1
Scoping & Access

NDA, P&L visibility, leadership alignment. Scope can be focused — a specific market, channel, or part of the business — or full-organization from the start.

Phase 1  ·  Weeks 2–5
30-Day Diagnostic Sprint

Distributor execution, full pricing and margin stack, commercial team structure. Output: a written 90-day action plan specific to this business.

Phase 2  ·  Months 2–4
Implementation

Execute the action plan. Distributor management, pricing recovery, team accountability frameworks in place and running.

Phase 3  ·  Month 5+
Ongoing Fractional Retainer (optional)

Commercial leadership on a fractional basis — as needed, as long as needed. Some engagements stop at Phase 1.

25 years inside wine & spirits.
At every level of the commercial system.

40%

Revenue Growth Delivered

Grew Chambers & Chambers from $16M to $22M in under 2 years. Director, Southern California — 20+ person team, 200+ supplier relationships.

$20M

P&L Owned at National VP Level

VP Sales & Marketing USA, Louis Latour Inc. Directed US commercial strategy for a 100,000-case Burgundy portfolio.

28

States — Distribution Built

President & GM, Fourcade & Hecht and A French Paradox. Spirits division scaled to 50%+ of total company revenue.

#1

National Ranking — 3 Years Running

Ste. Michelle Wine Estates, Luxury Division. Nicolas Feuillatte, Antinori, Stag’s Leap Wine Cellars.

“I have owned the P&L and been in the room when the distributor says no and the numbers don’t add up. Every recommendation comes from having run this business — not from studying it.”

François Beall. 25 years across every level of wine and spirits — founder, importer, distributor, luxury brand management, national VP. Born in France. Based in Southern California. Fluent in English, French, and Spanish.

P&L OwnershipDistributor Strategy Pricing ArchitectureTeam Structure European MarketsUS Market Entry
2002–06A French Paradox — Intern to majority owner. Strategic sale.
2006–12Fourcade & Hecht — President & GM. 28-state distribution. Spirits to 50%+ of revenue.
2013–17Ste. Michelle Wine Estates — Luxury Division. #1 national ranking 3 years running.
2017–23Chambers & Chambers — Director SoCal. $16M → $22M in under 2 years.
2024Louis Latour Inc. — VP Sales & Marketing USA. $20M P&L.

Four entry points.
One commercial discipline.

Importers

Distribution is in place. Velocity is below potential.

Agreements are signed. Product is in the system. But depletion is underperforming, programming is thin, and the distributor relationship has drifted toward passive management. The diagnostic identifies precisely where — and what to fix.

Distributor network audit and performance scoring
Pricing and margin recovery analysis
Portfolio prioritization and execution strategy
Distributors

The team is active. Revenue isn’t keeping pace.

Calls are being made. Samples are moving. But the gap between activity and revenue is widening. The diagnostic identifies exactly where performance is breaking down inside the commercial organization.

Sales team structure and performance analysis
Account universe and revenue gap identification
Portfolio mix and supplier relationship review
Producers & Wineries

Strong product. The U.S. commercial system isn’t converting it into revenue.

Whether the issue is importer alignment, distributor engagement, or pricing architecture — the system isn’t translating the product’s potential into revenue. The diagnostic audits all three and identifies where.

Importer capability and alignment assessment
Distributor network and depletion velocity review
US pricing architecture and channel analysis
International Wineries Entering the US

Entering or improving in the U.S. The commercial structure here is different from every other market.

Whether entering for the first time or fixing underperformance in an existing U.S. position — importer selection, three-tier pricing, distributor engagement, and tariff impact all require a specific commercial approach. The diagnostic is built for both. Conducted in English, French, or Spanish.

Importer selection and commercial alignment
Three-tier pricing and tariff impact modeling
US market entry roadmap — EN / FR / ES

Before the call.
The questions most people ask first.

If something isn’t answered here, the 20-minute diagnostic call is the right place to ask it.

Book a 20-minute
diagnostic call.

No pitch. No proposal. A direct conversation about where your commercial operation stands and whether execution gaps are costing you revenue. If it’s not a fit, that becomes clear quickly.

Schedule a Call with François

20 minutes. No preparation needed. You will leave with at least one specific area worth examining — whether or not we work together.

Book on Calendly →
francois.fhwines@gmail.com
(949) 400-8499
beallwineandspiritspartners.com